Roger Longman is a Managing Director, Pharma at Elsevier Business Intelligence, a Reed Elsevier company. In 1983, Longman joined The Wilkerson Group as a writer covering the pharmaceutical and biotech industries for IN VIVO: The Business & Medicine Report. In 1989, along with David Cassak, he led a buyout of IN VIVO, moved the newly created company-Windhover Information–to Connecticut. In addition to IN VIVO, Windhover now publishes Start-Up, The RPM Report, Medtech Insight, and The Strategic Transactions Database; produces a series of in-depth market reports on the device industry; and organizes a number of conferences, including Pharmaceutical Strategic Alliances and The FDA/CMS Summit. In 2004, Windhover acquired Medtech Insight, an information company covering the medical device field through a marketleading newsletter, a series of in-depth market reports, and a number of conferences. In 2008, Windhover was acquired by Reed Elsevier and merged with its FDC Reports division (publishers of The Pink Sheet, The Tan Sheet and many other medical-industry newsletters), creating Elsevier Business Intelligence. Over the years, Mr. Longman has become recognized as one of the leading experts in biopharmaceutical strategy and dealmaking. He is often asked to speak at many key industry events organized by important trade organizations like the Biotechnology Industry Organization (BIO), investment banks, venture capital firms and leading pharma and biotech companies. He lectures regularly at several leading universities. Mr. Longman completed his BA at Cornell University and an MA in English literature at the University of North Carolina at Chapel Hill.
